Showing 1 - 10 of 5,253
Health spending per capita in England has more than doubled since 1997, yet relatively little is known about how that … spending is distributed across the population. This paper uses administrative National Health Service (NHS) hospital records to … examine key features of public hospital spending in England. We describe how costs vary across the lifecycle, and the …
Persistent link: https://www.econbiz.de/10011526733
Many important decisions within public and private organizations are based on recommendations from expert committees and advisory boards. A notable example is the U.S. Food and Drug Administration's advisory committees, which make recommendations on new drug applications. Previously the voting...
Persistent link: https://www.econbiz.de/10011884455
words in relevant databased and websites. Data extracted included methods and empirical evidence (costs, effects … reported evidence. The included studies were also assessed for reporting quality using the Consolidated Health Economic …
Persistent link: https://www.econbiz.de/10013208837
Competition among health insurers is widely considered to be a means of enhancing efficiency and containing costs in … the health care system. In this paper, it is argued that this could be unsuccessful since health care providers hold a … strong position on the market for health care services. Physicians exert a type of monopolistic power which can be described …
Persistent link: https://www.econbiz.de/10010271400
firms, we then recover the marginal costs and markups. We finally evaluate the effect of the parallel imports' policy by …
Persistent link: https://www.econbiz.de/10010335860
, we then recover the marginal costs and markups. We finally evaluate the effect of the parallel imports' policy by …
Persistent link: https://www.econbiz.de/10010335929
availability of health-related products such as pharmaceuticals, vaccines, and medical equipment. The case for liberalizing trade …Trade in health products has been flourishing in recent years as the demand for better health has been growing … throughout the world. At the same time, trade in health products is hampered by substantive trade barriers. In this paper, we …
Persistent link: https://www.econbiz.de/10011688666
This paper studies the effect of a change in the mandatory manufacturer rebate on wholesale prices for pharmaceuticals …
Persistent link: https://www.econbiz.de/10011892151
pharmaceuticals on competition by parallel imports. First, I analyze the effect of a manufacturer rebate on competition by parallel …
Persistent link: https://www.econbiz.de/10011949036
We analyze the impact of national pharmaceutical regulation on the launch delay of new chemical entities approved by the EMEA's centralized procedure. We find that direct price control regimes have a significantly negative impact on the launch timing. These results cannot be found when...
Persistent link: https://www.econbiz.de/10010264890